Discrepancy in ER levels of breast carcinoma in biopsy vs mastectomy specimens
- 1 May 1985
- journal article
- research article
- Published by Wiley in Journal of Surgical Oncology
- Vol. 29 (1) , 54-56
- https://doi.org/10.1002/jso.2930290116
Abstract
The presence of estrogen receptors (ER) in breast tumors has been used by many as the major indicator for hormonal treatment of breast cancer. However, multiple factors have been shown to be involved in determining the hormone dependence of breast cancer. This paper reports another factor that influences the accuracy of ER determination. From January 1977 through December 1983 fifty‐eight (58) of these patients had ER determination of both biopsy and mastectomy specimens. Of the 31 patients that remained ER positive in mastectomy specimen, 13 had significantly lower ER levels (by at least 50%) from the mastectomy specimens. These findings indicate that ER status is greatly influenced by the source of the specimen.Keywords
This publication has 7 references indexed in Scilit:
- Estrogen and progesterone receptor assays on breast carcinoma from mastectomy specimensCancer, 1983
- Estrogen Receptor, a Marker for Human Breast Cancer Differentiation and Patient PrognosisPublished by Springer Nature ,1982
- OESTROGEN RECEPTORS IN BREAST CANCER: GREATER CARE IN COLLECTION*Anz Journal of Surgery, 1981
- Estrogen receptor: A prognostic factor in breast cancerCancer, 1981
- Comparison of estrogen receptor levels in breast cancer samples from mastectomy and frozen section specimensCancer, 1981
- CHARACTERISTICS OF THE DEXTRAN-COATED CHARCOAL ASSAY FOR ESTRADIOL RECEPTOR IN BREAST-CANCER PREPARATIONS1979
- Radio-Ligand Binding Assay of Specific Estrogens Using a Soluble Uterine MacromoleculeJournal of Clinical Endocrinology & Metabolism, 1968